These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27262115)

  • 61. Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
    Schapira E; Hubbeling H; Yeap BY; Mehan WA; Shaw AT; Oh K; Gainor JF; Shih HA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):624-629. PubMed ID: 29678530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis.
    Singh R; Bowden G; Mathieu D; Perlow HK; Palmer JD; Elhamdani S; Shepard M; Liang Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Elazzazi AH; Warnick RE; Gozal YM; Daly M; McShane B; Addis-Jackson M; Karthikeyan G; Smith S; Picozzi P; Franzini A; Kaisman-Elbaz T; Yang HC; Wei Z; Legarreta A; Hess J; Templeton K; Pikis S; Mantziaris G; Simonova G; Liscak R; Peker S; Samanci Y; Chiang V; Niranjan A; Kersh CR; Lee CC; Trifiletti DM; Lunsford LD; Sheehan JP
    Neurosurgery; 2023 Sep; 93(3):592-598. PubMed ID: 36942965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?
    Chang WS; Kim HY; Chang JW; Park YG; Chang JH
    J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma.
    Voynov G; Heron DE; Burton S; Grandis J; Quinn A; Ferris R; Ozhasoglu C; Vogel W; Johnson J
    Technol Cancer Res Treat; 2006 Oct; 5(5):529-35. PubMed ID: 16981796
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review.
    Murray L; Menard C; Zadeh G; Au K; Bernstein M; Millar BA; Laperriere N; Chung C
    J Radiat Oncol; 2017; 6(1):21-30. PubMed ID: 28367275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.
    Seastone DJ; Elson P; Garcia JA; Chao ST; Suh JH; Angelov L; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):111-6. PubMed ID: 24331575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Edema following Gamma Knife radiosurgery for parasagittal and parafalcine meningiomas.
    Sheehan JP; Lee CC; Xu Z; Przybylowski CJ; Melmer PD; Schlesinger D
    J Neurosurg; 2015 Nov; 123(5):1287-93. PubMed ID: 26115473
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
    Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
    J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery.
    Raldow AC; Chiang VL; Knisely JP; Yu JB
    Am J Clin Oncol; 2013 Oct; 36(5):486-90. PubMed ID: 22706180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.
    Kakusa B; Han S; Aggarwal S; Liu B; Li G; Soltys S; Hayden Gephart M
    J Neurooncol; 2018 Dec; 140(3):705-715. PubMed ID: 30460628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calvarial and skull base metastases: expanding the clinical utility of Gamma Knife surgery.
    Kotecha R; Angelov L; Barnett GH; Reddy CA; Suh JH; Murphy ES; Neyman G; Chao ST
    J Neurosurg; 2014 Dec; 121 Suppl():91-101. PubMed ID: 25434942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
    Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Prognostic Role of Tumor Volume in the Outcome of Patients with Single Brain Metastasis After Stereotactic Radiosurgery.
    Bennett EE; Angelov L; Vogelbaum MA; Barnett GH; Chao ST; Murphy ES; Yu JS; Suh JH; Jia X; Stevens GHJ; Ahluwalia MS; Mohammadi AM
    World Neurosurg; 2017 Aug; 104():229-238. PubMed ID: 28478250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies.
    Choong ES; Lo S; Drummond M; Fogarty GB; Menzies AM; Guminski A; Shivalingam B; Clarke K; Long GV; Hong AM
    Eur J Cancer; 2017 Apr; 75():169-178. PubMed ID: 28236768
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
    Ehret F; Rueß D; Blanck O; Fichte S; Chatzikonstantinou G; Wolff R; Mose L; Mose S; Fortmann T; Lehrke R; Turna M; Caglar HB; Mortasawi F; Bleif M; Krug D; Ruge MI; Fürweger C; Muacevic A
    Int J Cancer; 2024 Sep; 155(5):916-924. PubMed ID: 38720427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.